| Literature DB >> 27597310 |
Mirko Signorelli1,2, Veronica Vinciotti3, Ernst C Wit4.
Abstract
BACKGROUND: Network enrichment analysis is a powerful method, which allows to integrate gene enrichment analysis with the information on relationships between genes that is provided by gene networks. Existing tests for network enrichment analysis deal only with undirected networks, they can be computationally slow and are based on normality assumptions.Entities:
Keywords: Enrichment analysis; Gene expression; Hypergeometric; Network
Mesh:
Year: 2016 PMID: 27597310 PMCID: PMC5011912 DOI: 10.1186/s12859-016-1203-6
Source DB: PubMed Journal: BMC Bioinformatics ISSN: 1471-2105 Impact factor: 3.169
Fig. 1Workflow diagram of a typical network enrichment analysis with NEAT
Fig. 2Example: NEAT in directed networks. Left: directed network consisting of 8 nodes connected by 15 arrows. Set A contains nodes 1 and 4 (red) and set B nodes 3, 5 and 7 (orange). Right: bipartite representation of the same network: it can be observed that n =2, o =5, i =4 and i =15. It follows that μ 0=1.07 and p=0.48
Fig. 3Example: NEAT in undirected networks. Left: undirected network with 12 nodes. We are interested to infer the relation between sets A (nodes 1 and 5), B (2, 4 and 7) and C (6 and 8). Right: representation of the relations between sets: enrichment is detected between sets A and B (p=0.023) and between sets B and C (p=0.038), but not between sets A and C (p=0.465)
An overview of simulations S1–S5
| Simulation | Network type | Degree distribution | Graph density | Mean overlap | Maximum overlap |
|---|---|---|---|---|---|
| S1 | Directed | Power law | 3 % | 4 % | 11.3 % |
| S2 | Directed | Mixture of 2 Poisson | 4 % | 3.6 % | 9.5 % |
| S3 | Directed | Mixture of 2 Poisson | 4 % | – | – |
| S4 | Undirected | Power law | 3 % | 3.8 % | 12 % |
| S5 | Undirected | Mixture of 2 Poisson | 4 % | 3.6 % | 11 % |
In Simulations S1 and S2, we compare the performance of NEAT in two directed networks with different degree distribution. In simulation S3, we check the performance of the test for different levels of overlap, ranging from 0 to 100 %. In Simulations S4 and S5, we compare NEAT to alternative tests in two undirected networks with different degree distribution
Performance of NEAT in simulations S1 and S2
| Simulation |
|
|
| Sensitivity | Specificity | AUC |
|---|---|---|---|---|---|---|
| S1 | 0.510 | 1.56 | 1.17 | 73 % | 94 % | 0.894 |
| S2 | 0.125 | 1.20 | 1.12 | 78 % | 94 % | 0.927 |
p denotes the p-value of the Kolmogorov-Smirnov test for uniform distribution, AUC is an abbreviation for “area under the ROC curve”. In both simulations, the distribution of p-values under H 0 is uniform and the specificity is close to the expected 95 % value. Sensitivity and AUC are higher in simulation S2
Fig. 4Specificity and sensitivity in simulation S3. The plot shows the values of specificity and sensitivity for different levels of overlap (every point in the plot is computed on the basis of 1000 tests). We observe that the specificity of the test does not vary substantially for different levels of overlap, and is always close to 95 % as expected. The sensitivity, instead, slightly reduces as the percentage of overlap increases
Results of simulation S4
| Test |
|
|
| Sensitivity | Specificity | AUC |
|---|---|---|---|---|---|---|
| NEAT |
| 1.33 |
|
|
|
|
| NEA | 0.001 | 0 |
|
|
|
|
| LP | 0 | 2.13 | 1.51 |
| 92 % | 0.908 |
| LA |
| 1.60 | 1.17 | 60 % |
| 0.897 |
| LA+S |
| 1.87 | 1.17 | 63 % |
| 0.913 |
| NP | 0.037 |
| 1.28 | 58 % |
| 0.884 |
The best results for each indicator are in bold. p denotes the p-value of the Kolmogorov-Smirnov test for uniform distribution, AUC is an abbreviation for “area under the ROC curve”. The distribution of p-values under H 0 is evidently not uniform for NEA and LP. NEAT shows the highest values of sensitivity and AUC, and its specificity is close to the target value (95 %)
Results of simulation S5
| Test |
|
|
| Sensitivity | Specificity | AUC |
|---|---|---|---|---|---|---|
| NEAT |
| 0.62 |
|
|
|
|
| NEA | 0.024 | 0 | 0.82 | 73 % | 96 % | 0.912 |
| LP | 0 | 1.33 | 1.51 |
| 92 % | 0.904 |
| LA |
|
| 1.33 | 73 % | 93 % | 0.908 |
| LA+S | 0.024 |
| 1.13 | 76 % | 94 % | 0.910 |
| NP |
| 1.42 | 1.16 | 70 % | 94 % | 0.908 |
The best results for each indicator are in bold. p denotes the p-value of the Kolmogorov-Smirnov test for uniform distribution, AUC is an abbreviation for “area under the ROC curve”. The distribution of p-values under H 0 can be considered uniform for NEAT, LA and NP, and is questionable for LA+S. NEAT shows the highest values of sensitivity and AUC, and its specificity is exactly equal to the target value (95 %)
Fig. 5Histogram of p-values in absence of enrichment in simulation S4. The test of Kolmogorov-Smirnov indicates that the distribution is uniform for NEAT (p=0.34), LA (p=0.11) and NP (p=0.32). The distribution of p-values is highly left-skewed for NEA, and right-skewed for LP
Speed comparison
| Test | Software | Simulation S4 | Simulation S5 |
|---|---|---|---|
| NEAT | R package neat | 0.6 | 0.7 |
| NEA | R package neaGUI | 2125.4 | 2151.5 |
| LP | CrossTalkZ | 28.6 | 44.7 |
| LA | CrossTalkZ | 14.4 | 18.0 |
| LA+S | CrossTalkZ | 21.8 | 27.6 |
| NP | CrossTalkZ | 12.9 | 15.8 |
The table compares the time (in seconds) that each method required to compute 1225 tests for enrichment in simulations S4 and S5, using a processor with 2.5 GhZ CPU frequency. NEAT turns out to be by far the fastest method
Network enrichment analysis of the repressed ESR gene set
| Gene set |
|
|
| |
|---|---|---|---|---|
| Go Slim BP sets: | ||||
| 1 | Cytoplasmic translation | 6878 | 2641.9 | <-300 |
| 2 | Ribosomal large subunit biogenesis | 3408 | 1097.8 | <-300 |
| 3 | Ribosomal small subunit biogenesis | 5861 | 2073.7 | <-300 |
| 4 | Ribosome assembly | 1782 | 621.9 | <-300 |
| 5 | RNA modification | 2944 | 1062.0 | <-300 |
| 6 | rRNA processing | 9187 | 3290.2 | <-300 |
| 7 | tRNA processing | 2037 | 901.0 | <-300 |
| 8 | Translational elongation | 1786 | 782.3 | –283.8 |
| 9 | Ribosomal subunit export from nucleus | 1420 | 561.4 | –281.8 |
| 10 | Translational initiation | 939 | 462.5 | –112.1 |
| 11 | Transcription from RNA polymerase III promoter | 565 | 228.4 | –107.7 |
| 12 | SnoRNA processing | 634 | 303.3 | –82.0 |
| 13 | Regulation of translation | 1952 | 1328.6 | –73.5 |
| 14 | DNA-dependent transcription, termination | 774 | 447.0 | –57.5 |
| 15 | Transcription from RNA polymerase I promoter | 1005 | 646.4 | –49.5 |
| 16 | Protein alkylation | 1063 | 759.4 | –31.4 |
| 17 | tRNA aminoacylation for protein translation | 400 | 233.1 | –29.4 |
| 18 | Peptidyl-amino acid modification | 1088 | 883.0 | –13.2 |
| 19 | Nuclear transport | 3154 | 2003.5 | –162.4 |
| 20 | Organelle assembly | 2090 | 1362.7 | –96.1 |
| 21 | Nucleobase-containing compound transport | 1453 | 1155.4 | –20.8 |
| 22 | Cytokinesis | 1024 | 806.9 | –16.0 |
| 23 | Vitamin metabolic process | 325 | 274.0 | –3.1 |
| KEGG pathways: | ||||
| 24 | Ribosome biogenesis in eukaryotes | 9824 | 3661.0 | <-300 |
| 25 | Ribosome | 18640 | 8731.7 | <-300 |
| 26 | RNA polymerase | 3057 | 1541.2 | <-300 |
| 27 | RNA transport | 4341 | 2906.4 | –177.6 |
| 28 | Aminoacyl-tRNA biosynthesis | 1433 | 960.9 | –58.2 |
| 29 | RNA degradation | 2560 | 1939.3 | –51.9 |
| 30 | mRNA surveillance pathway | 1768 | 1413.5 | –24.0 |
| 31 | Pentose phosphate pathway | 1126 | 947.1 | –9.7 |
| 32 | Spliceosome | 2649 | 2523.6 | –2.3 |
| 33 | Purine metabolism | 5579 | 3623.0 | –263.6 |
| 34 | Pyrimidine metabolism | 4541 | 2884.5 | –234.9 |
| 35 | Cyanoamino acid metabolism | 218 | 158.8 | –6.3 |
| 36 | One carbon pool by folate | 541 | 392.5 | –15.0 |
| 37 | Sulfur relay system | 238 | 196.5 | –2.9 |
| 38 | Carbapenem biosynthesis | 117 | 89.8 | –2.7 |
The table lists the 23 Go Slim BP gene sets and the 15 KEGG pathways which the set of repressed ESR genes is found to be over-enriched with at 1 % significance level
Network enrichment analysis of the induced ESR gene set (KEGG pathways)
| KEGG pathway |
|
|
| |
|---|---|---|---|---|
| 1 | Starch and sucrose metabolism | 1436 | 394.2 | <-300 |
| 2 | Pentose and glucuronate interconversions | 414 | 110.7 | –119.9 |
| 3 | Glycolysis/Gluconeogenesis | 1235 | 616.3 | –116.5 |
| 4 | Fructose and mannose metabolism | 562 | 200.0 | –106.7 |
| 5 | Galactose metabolism | 511 | 173.9 | –104.5 |
| 6 | Amino sugar and nucleotide sugar metabolism | 567 | 264.2 | –63.4 |
| 7 | Other glycan degradation | 79 | 11.7 | –44.2 |
| 8 | Pyruvate metabolism | 633 | 355.9 | –42.8 |
| 9 | Propanoate metabolism | 189 | 107.3 | –12.9 |
| 10 | Glycerolipid metabolism | 444 | 172.1 | –72.7 |
| 11 | Peroxisome | 633 | 313.3 | –61.2 |
| 12 | Fatty acid degradation | 419 | 215.0 | –37.2 |
| 13 | Arachidonic acid metabolism | 117 | 36.7 | –28.1 |
| 14 | Sphingolipid metabolism | 227 | 103.6 | –27.3 |
| 15 | Glycerophospholipid metabolism | 450 | 270.9 | –24.5 |
| 16 | alpha-Linolenic acid metabolism | 69 | 27.1 | –11.7 |
| 17 | Fatty acid elongation | 138 | 75.3 | –10.8 |
| 18 | Biosynthesis of unsaturated fatty acids | 134 | 103.9 | –2.5 |
| 19 | Glutathione metabolism | 467 | 204.8 | –59.9 |
| 20 | Citrate cycle (TCA cycle) | 487 | 267.3 | –35.6 |
| 21 | Ubiquinone and other terpenoid-quinone biosynthesis | 96 | 41.8 | –13.1 |
| 22 | Protein processing in endoplasmic reticulum | 1121 | 866.0 | –17.4 |
| 23 | Longevity regulating pathway | 987 | 544.0 | –70.6 |
| 24 | beta-Alanine metabolism | 397 | 104.0 | –118.0 |
| 25 | Taurine and hypotaurine metabolism | 132 | 24.3 | –59.4 |
| 26 | Tyrosine metabolism | 382 | 163.5 | –51.8 |
| 27 | Tryptophan metabolism | 292 | 113.3 | –48.2 |
| 28 | Valine, leucine and isoleucine degradation | 276 | 107.5 | –45.3 |
| 29 | Alanine, aspartate and glutamate metabolism | 488 | 262.2 | –38.0 |
| 30 | Histidine metabolism | 267 | 127.4 | –28.8 |
| 31 | Arginine and proline metabolism | 301 | 154.3 | –27.0 |
| 32 | Lysine degradation | 294 | 150.4 | –26.6 |
| 33 | Phenylalanine metabolism | 171 | 71.4 | –25.0 |
| 34 | Glycine, serine and threonine metabolism | 350 | 264.3 | –6.7 |
| 35 | Cysteine and methionine metabolism | 338 | 285.3 | –2.8 |
| 36 | Arginine biosynthesis | 167 | 134.0 | –2.4 |
| 37 | Butanoate metabolism | 460 | 84.8 | –202.8 |
| 38 | Pentose phosphate pathway | 604 | 288.0 | –64.0 |
| 39 | Regulation of autophagy | 303 | 126.7 | –43.3 |
| 40 | Insulin resistance | 337 | 172.8 | –30.1 |
| 41 | Glyoxylate and dicarboxylate metabolism | 368 | 201.6 | –27.3 |
| 42 | Methane metabolism | 435 | 254.2 | –26.2 |
| 43 | Nicotinate and nicotinamide metabolism | 154 | 99.8 | –6.7 |
| 44 | Nitrogen metabolism | 88 | 52.8 | –5.4 |
| 45 | Thiamine metabolism | 57 | 32.9 | –4.1 |
| 46 | Selenocompound metabolism | 122 | 89.3 | –3.2 |
| 47 | Sulfur metabolism | 133 | 105.3 | –2.2 |
The table lists the 47 KEGG pathways which the set of induced ESR genes is found to be over-enriched with at 1 % significance level
Network enrichment analysis of the induced ESR gene set (GO Slim sets)
| GO Slim BP gene set |
|
|
| |
|---|---|---|---|---|
| 1 | Carbohydrate metabolic process | 1296 | 671.2 | –110.9 |
| 2 | Oligosaccharide metabolic process | 442 | 165.3 | –77.3 |
| 3 | Carbohydrate transport | 202 | 65.8 | –45.0 |
| 4 | Lipid metabolic process | 693 | 484.4 | –19.9 |
| 5 | Peroxisome organization | 181 | 124.8 | –6.0 |
| 6 | Lipid transport | 120 | 79.7 | –4.9 |
| 7 | Generation of precursor metabolites and energy | 585 | 294.8 | –54.0 |
| 8 | Cellular respiration | 210 | 118.4 | –14.5 |
| 9 | Proteolysis involved in cellular protein catabolic process | 639 | 488.5 | –10.9 |
| 10 | Protein folding | 476 | 296.9 | –22.7 |
| 11 | Response to oxidative stress | 813 | 242.2 | –202.7 |
| 12 | Response to chemical stimulus | 1489 | 885.1 | –83.4 |
| 13 | Response to starvation | 459 | 331.4 | –11.2 |
| 14 | Transmembrane transport | 910 | 644.4 | –24.2 |
| 15 | Endocytosis | 395 | 245.5 | –19.3 |
| 16 | Protein targeting | 628 | 478.8 | –10.9 |
| 17 | Ion transport | 464 | 380.2 | –4.8 |
| 18 | Amino acid transport | 137 | 109.4 | –2.1 |
| 19 | Cofactor metabolic process | 523 | 219.0 | –73.7 |
| 20 | Nucleobase-containing small molecule metabolic process | 722 | 404.5 | –49.2 |
| 21 | Membrane invagination | 278 | 120.6 | –37.0 |
| 22 | Vacuole organization | 335 | 200.2 | –18.9 |
| 23 | Protein maturation | 49 | 27.7 | –3.9 |
| 24 | Cell morphogenesis | 113 | 79.4 | –3.6 |
| 25 | Sporulation | 352 | 306.4 | –2.1 |
The table lists the 25 Go Slim BP gene sets which the set of induced ESR genes is found to be over-enriched with at 1 % significance level
Repressed ESR gene set: comparison between NEAT and LA+S
|
| log10 ( | ||||
|---|---|---|---|---|---|
| Gene set | NEAT | LA+S | NEAT | LA+S | |
| GO Slim BP sets: | |||||
| 1 | Cytoplasmic translation | 2641.9 | 3583.5 | <-300 | –290.9 |
| 2 | Ribosomal large subunit biogenesis | 1097.8 | 1602.4 | <-300 | –269.2 |
| 3 | Ribosomal small subunit biogenesis | 2073.7 | 3013.2 | <-300 | –236.8 |
| 4 | Ribosome assembly | 621.9 | 872.1 | <-300 | –95.9 |
| 5 | RNA modification | 1062.0 | 1422.7 | <-300 | –213.7 |
| 6 | rRNA processing | 3290.2 | 4623.2 | <-300 | <-300 |
| 7 | tRNA processing | 901.0 | 1137.6 | <-300 | –103.3 |
| 8 | Translational elongation | 782.3 | 1019.5 | –283.8 | –71.2 |
| 9 | Ribosomal subunit export from nucleus | 561.4 | 693.4 | –281.8 | –151.2 |
| 10 | Nuclear transport | 2003.5 | 2452.5 | –162.4 | –33.0 |
| 11 | Translational initiation | 462.5 | 594.8 | –112.1 | –33.6 |
| 12 | Transcription from RNA polymerase III promoter | 228.4 | 281.6 | –107.7 | –43.6 |
| 13 | Organelle assembly | 1362.7 | 1719.2 | –96.1 | –8.0 |
| 14 | SnoRNA processing | 303.3 | 349.8 | –82.0 | –26.5 |
| 15 | Regulation of translation | 1328.6 | 1577.5 | –73.5 | –12.9 |
| 16 | DNA-dependent transcription, termination | 447.0 | 575.2 | –57.5 | –11.7 |
| 17 | Transcription from RNA polymerase I promoter | 646.4 | 874.2 | –49.5 | –5.2 |
| 18 | tRNA aminoacylation for protein translation | 233.1 | 256.7 | –29.4 | –11.2 |
| 19 | Protein alkylation | 759.4 | 1000.0 | –31.4 | –1.2 |
| 20 | Nucleobase-containing compound transport | 1155.4 | 1445.1 | –20.8 | –0.1 |
| 21 | Cytokinesis | 806.9 | 925.9 | –16.0 | –1.8 |
| 22 | Peptidyl-amino acid modification | 883.0 | 1102.4 | –13.2 | –0.1 |
| 23 | Vitamin metabolic process | 274.0 | 245.8 | –3.1 | –5.5 |
| KEGG pathways: | |||||
| 24 | Ribosome biogenesis in eukaryotes | 3661.0 | 5212.5 | <-300 | <-300 |
| 25 | Ribosome | 8731.7 | 11954.0 | <-300 | –283.3 |
| 26 | RNA polymerase | 1541.2 | 2058.0 | <-300 | –76.1 |
| 27 | Purine metabolism | 3623.0 | 4136.9 | –263.6 | –66.9 |
| 28 | Pyrimidine metabolism | 2884.5 | 3402.5 | –234.9 | –61.0 |
| 29 | RNA transport | 2906.4 | 3193.2 | –177.6 | –75.4 |
| 30 | Aminoacyl-tRNA biosynthesis | 960.9 | 934.2 | –58.2 | –49.8 |
| 31 | RNA degradation | 1939.3 | 2051.3 | –51.9 | –19.9 |
| 32 | mRNA surveillance pathway | 1413.5 | 1477.3 | –24.0 | –12.7 |
| 33 | One carbon pool by folate | 392.5 | 344.2 | –15.0 | –19.5 |
| 34 | Pentose phosphate pathway | 947.1 | 979.2 | –9.7 | –4.6 |
| 35 | Cyanoamino acid metabolism | 158.8 | 132.2 | –6.3 | –7.2 |
| 36 | Sulfur relay system | 196.5 | 172.7 | –2.9 | –3.9 |
| 37 | Carbapenem biosynthesis | 89.8 | 75.1 | –2.7 | –4.1 |
| 38 | Spliceosome | 2523.6 | 2432.2 | –2.3 | –4.1 |
| 39 | Synthesis and degradation of ketone bodies | 39.8 | 29.8 | –0.3 | –2.2 |
The table reports the gene sets that are found to be over-enriched (α=1 %) by at least one of the two methods. μ 0 denotes the expected value of N in the absence of enrichment. The last two columns report log 10 p-values for the proposed NEAT and the LA+S test of [19], respectively
Induced ESR gene set: comparison between NEAT and LA+S (GO Slim sets)
|
| log10 ( | ||||
|---|---|---|---|---|---|
| GO Slim BP set | NEAT | LA+S | NEAT | LA+S | |
| 1 | Response to oxidative stress | 242.2 | 248.5 | –202.7 | –253.7 |
| 2 | Carbohydrate metabolic process | 671.2 | 663.9 | –110.9 | –123.3 |
| 3 | Response to chemical stimulus | 885.1 | 912.4 | –83.4 | –92.8 |
| 4 | Oligosaccharide metabolic process | 165.3 | 158.1 | –77.3 | –104.5 |
| 5 | Cofactor metabolic process | 219.0 | 225.6 | –73.7 | –76.2 |
| 6 | Generation of precursor metabolites and energy | 294.8 | 293.4 | –54.0 | –56.1 |
| 7 | Nucleobase-containing small molecule metabolic process | 404.5 | 417.4 | –49.2 | –41.0 |
| 8 | Carbohydrate transport | 65.8 | 77.7 | –45.0 | –52.8 |
| 9 | Membrane invagination | 120.6 | 118.3 | –37.0 | –51.7 |
| 10 | Transmembrane transport | 644.4 | 684.7 | –24.2 | –16.2 |
| 11 | Protein folding | 296.9 | 296.3 | –22.7 | –26.6 |
| 12 | Lipid metabolic process | 484.4 | 495.7 | –19.9 | –23.3 |
| 13 | Endocytosis | 245.5 | 248.7 | –19.3 | –19.3 |
| 14 | Vacuole organization | 200.2 | 199.7 | –18.9 | –22.4 |
| 15 | Cellular respiration | 118.4 | 125.2 | –14.5 | –14.1 |
| 16 | Response to starvation | 331.4 | 318.4 | –11.2 | –15.8 |
| 17 | Protein targeting | 478.8 | 485.1 | –10.9 | –15.8 |
| 18 | Proteolysis involved in cellular protein catabolic process | 488.5 | 494.1 | –10.9 | –9.8 |
| 19 | Peroxisome organization | 124.8 | 123.5 | –6.0 | –6.0 |
| 20 | Lipid transport | 79.7 | 90.4 | –4.9 | –2.8 |
| 21 | Ion transport | 380.2 | 410.7 | –4.8 | –2.1 |
| 22 | Protein maturation | 27.7 | 30.9 | –3.9 | –3.0 |
| 23 | Cell morphogenesis | 79.4 | 80.8 | –3.6 | –3.7 |
| 24 | Sporulation | 306.4 | 301.7 | –2.1 | –2.5 |
| 25 | Amino acid transport | 109.4 | 113.0 | –2.1 | –1.6 |
| 26 | Response to osmotic stress | 181.8 | 178.3 | –1.6 | –2.1 |
| 27 | Protein phosphorylation | 587.6 | 564.3 | –1.4 | –2.7 |
The table reports the gene sets that are found to be over-enriched (α=1 %) by at least one of the two methods. μ 0 denotes the expected value of N in the absence of enrichment. The last two columns report log 10 p-values for the proposed NEAT and the LA+S test of [19], respectively
Induced ESR gene set: comparison between NEAT and LA+S (KEGG pathways)
|
| log10 ( | ||||
|---|---|---|---|---|---|
| KEGG pathway | NEAT | LA+S | NEAT | LA+S | |
| 1 | Starch and sucrose metabolism | 394.2 | 400.6 | <-300 | <-300 |
| 2 | Butanoate metabolism | 84.8 | 98.0 | –202.8 | <-300 |
| 3 | Pentose and glucuronate interconversions | 110.7 | 127.5 | –119.9 | –185.7 |
| 4 | beta-Alanine metabolism | 104.0 | 122.9 | –118.0 | –209.8 |
| 5 | Glycolysis/Gluconeogenesis | 616.3 | 618.7 | –116.5 | –149.3 |
| 6 | Fructose and mannose metabolism | 200.0 | 206.2 | –106.7 | –160.7 |
| 7 | Galactose metabolism | 173.9 | 193.2 | –104.5 | –126.4 |
| 8 | Glycerolipid metabolism | 172.1 | 193.2 | –72.7 | –103.2 |
| 9 | Longevity regulating pathway - multiple species | 544.0 | 508.2 | –70.6 | –79.1 |
| 10 | Pentose phosphate pathway | 288.0 | 284.2 | –64.0 | –105.8 |
| 11 | Amino sugar and nucleotide sugar metabolism | 264.2 | 277.6 | –63.4 | –66.7 |
| 12 | Peroxisome | 313.3 | 332.9 | –61.2 | –55.8 |
| 13 | Glutathione metabolism | 204.8 | 221.6 | –59.9 | –77.8 |
| 14 | Taurine and hypotaurine metabolism | 24.3 | 28.5 | –59.4 | –92.8 |
| 15 | Tyrosine metabolism | 163.5 | 169.9 | –51.8 | –62.6 |
| 16 | Tryptophan metabolism | 113.3 | 130.9 | –48.2 | –59.4 |
| 17 | Valine, leucine and isoleucine degradation | 107.5 | 124.8 | –45.3 | –56.8 |
| 18 | Other glycan degradation | 11.7 | 12.9 | –44.2 | –66.3 |
| 19 | Regulation of autophagy | 126.7 | 135.2 | –43.3 | –45.5 |
| 20 | Pyruvate metabolism | 355.9 | 388.8 | –42.8 | –41.6 |
| 21 | Alanine, aspartate and glutamate metabolism | 262.2 | 284.5 | –38.0 | –36.7 |
| 22 | Fatty acid degradation | 215.0 | 225.0 | –37.2 | –43.7 |
| 23 | Citrate cycle (TCA cycle) | 267.3 | 299.5 | –35.6 | –32.9 |
| 24 | Insulin resistance | 172.8 | 176.5 | –30.1 | –30.4 |
| 25 | Histidine metabolism | 127.4 | 147.8 | –28.8 | –25.8 |
| 26 | Arachidonic acid metabolism | 36.7 | 44.1 | –28.1 | –40.6 |
| 27 | Glyoxylate and dicarboxylate metabolism | 201.6 | 224.8 | –27.3 | –23.7 |
| 28 | Sphingolipid metabolism | 103.6 | 116.3 | –27.3 | –26.2 |
| 29 | Arginine and proline metabolism | 154.3 | 180.2 | –27.0 | –24.8 |
| 30 | Lysine degradation | 150.4 | 160.2 | –26.6 | –31.5 |
| 31 | Methane metabolism | 254.2 | 262.7 | –26.2 | –23.7 |
| 32 | Phenylalanine metabolism | 71.4 | 81.5 | –25.0 | –26.4 |
| 33 | Glycerophospholipid metabolism | 270.9 | 285.1 | –24.5 | –22.3 |
| 34 | Protein processing in endoplasmic reticulum | 866.0 | 857.1 | –17.4 | –20.7 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis | 41.8 | 47.1 | –13.1 | –12.3 |
| 36 | Propanoate metabolism | 107.3 | 122.9 | –12.9 | –9.9 |
| 37 | alpha-Linolenic acid metabolism | 27.1 | 30.5 | –11.7 | –11.2 |
| 38 | Fatty acid elongation | 75.3 | 76.1 | –10.8 | –12.9 |
| 39 | Glycine, serine and threonine metabolism | 264.3 | 281.1 | –6.7 | –3.5 |
| 40 | Nicotinate and nicotinamide metabolism | 99.8 | 111.9 | –6.7 | –4.7 |
| 41 | Nitrogen metabolism | 52.8 | 60.7 | –5.4 | –4.0 |
| 42 | Thiamine metabolism | 32.9 | 36.8 | –4.1 | –3.2 |
| 43 | Selenocompound metabolism | 89.3 | 97.0 | –3.2 | –1.9 |
| 44 | Cysteine and methionine metabolism | 285.3 | 310.6 | –2.8 | –1.0 |
| 45 | Arginine biosynthesis | 134.0 | 154.2 | –2.4 | –0.6 |
| 46 | Sulfur metabolism | 105.3 | 121.9 | –2.2 | –0.5 |
| 47 | Biosynthesis of unsaturated fatty acids | 103.9 | 102.1 | –2.5 | –3.1 |
| 48 | Regulation of mitophagy - yeast | 554.4 | 510.4 | –1.6 | –5.1 |
The table reports the gene sets that are found to be over-enriched (α=1 %) by at least one of the two methods. μ 0 denotes the expected value of N in absence of enrichment. The last two columns report log 10 p-values for the proposed NEAT and the LA+S test of [19], respectively
Fig. 6Relation between overlap (J ) and p-values. Note that p-values are represented on a negative log-scale to enhance readability